Stay updated with breaking news from Virtual Bioconnect. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing vaccines, today...
/PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its...
Apexigen to Present at Virtual Investor Conferences News provided by Share this article Share this article SAN CARLOS, Calif., Jan. 7, 2021 /PRNewswire/ -- Apexigen, Inc., a clinical-stage biopharmaceutical company, today announced that Xiaodong Yang, M.D., Ph.D., President and Chief Executive Officer, will participate in two upcoming virtual investor healthcare conferences: The Solebury Trout Virtual Management Access Event being held January 6 – 15, 2021. The Company will be conducting one-on-one meetings. H.C. Wainwright Virtual BioConnect 2021 Conference. The Company's presenta...
ANN ARBOR, MI / ACCESSWIRE / January 8, 2021 / ENDRA Life Sciences Inc. (ENDRA) (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that Chairman and CEO Francois Michelon
Aurinia Pharmaceuticals to Present at Two Upcoming Virtual Healthcare Conferences Aurinia Pharmaceuticals Inc. today announced that members of the management team will participate in two upcoming virtual investor conferences and participate in a panel discussion hosted by Dr. Scott Gottlieb, former FDA Commissioner: H.C. Wainwright Virtual BioConnect 2021 Conference. On-demand fireside chat available beginning Monday, January 11, 2021 at 6:00 a.m. EST; Scott Gottlieb, M.D. Hosts a Panel … Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the “Company”) today announced that member...